QUOTE AND NEWS
OilVoice  Apr 22  Comment 
Hyperion Exploration Corp. TSX VENTUREHYX is pleased to announce significant 2012 year end reserve growth an operations update highlighting success at the NitonMcLeod light oil Cardium play and
Benzinga  Mar 13  Comment 
Hyperion Therapeutics, Inc. (Nasdaq: HPTX) announced today the completion of its follow-on offering of 2,875,000 shares of common stock. In addition, the underwriters exercised their over-allotment option in full and purchased an additional...
StreetInsider.com  Mar 8  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Hyperion+%28HPTX%29+Prices+2.88M+Common+Follow-On+Offering/8169251.html for the full story.
Wall Street Journal  Mar 6  Comment 
Walt DisneyCo.'s Hyperion Books is putting its backlist of older titles on the market, as part of a shift in strategy that will see it focus on publishing books linked to television properties.
StreetInsider.com  Feb 26  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Equity+Offerings/Hyperion+Therapeutics+%28HPTX%29+Files+%2450M+Common+Shelf+for+Shareholders/8135152.html for the full story.
StreetInsider.com  Feb 25  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Hyperion+Thptcs+%28HPTX%29+Posts+Q4+Loss+of+50cShare/8127052.html for the full story.
Cloud Computing  Feb 13  Comment 
Oracle (NASDAQ: ORCL) read more
Benzinga  Feb 1  Comment 
Hyperion Therapeutics, Inc. (Nasdaq: HPTX) today announced that the U.S. Food and Drug Administration (FDA) has approved RAVICTI for the treatment of Urea Cycle Disorders (UCD) in patients two years of age and older. The drug is expected to be...
Benzinga  Jan 16  Comment 
Hyperion Therapeutics, Inc. (Nasdaq: HPTX) said that the U.S. Food and Drug Administration (FDA) has advised the Company not to expect a final action by the Prescription Drug User Fee Act (PDUFA) action date of January 23, 2013. The agency...





 


References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki